Sustained Benefit 20 Years After Reperfusion Therapy in Acute Myocardial Infarction
Ron T. van Domburg, PhD*,*,
Karel Sonnenschein, MSc*,
Robby Nieuwlaat, MSc ,
Otto Kamp, MD, PhD ,
Corstiaan J. Storm, MD ,
Jeroen J. Bax, MD, PhD|| and
Maarten L. Simoons, MD, PhD*
* Thoraxcenter, Erasmus Medical Center Rotterdam, Rotterdam, the Netherlands
University Hospital Maastricht, Maastricht, the Netherlands
VU University Medical Center Amsterdam, Amsterdam, the Netherlands
Medical Center Rijnmond Zuid Rotterdam, Rotterdam, the Netherlands
|| Leids University Medical Center Leiden, Leiden, the Netherlands

View larger version (18K):
[in a new window]
|
Figure 1 Cumulative survival after reperfusion therapy or conventional therapy.
|
|

View larger version (22K):
[in a new window]
|
Figure 2 (a) Yearly incidence of myocardial re-infarction. (b) Yearly incidence of revascularization (coronary bypass surgery or coronary angioplasty). *Five-year average.
|
|
|